
Important press release
A company announces it can submit a treatment for ATTR amyloidosis to health authorities. Access to treatment must now reach patients in every country.
Newsroom


A company announces it can submit a treatment for ATTR amyloidosis to health authorities. Access to treatment must now reach patients in every country.

In New Zealand, Professor Ed Gane is working with families affected by hereditary amyloidosis, as research into new treatment approaches brings new hope.

Amyloidosis explained: how amyloid deposits affect the organs, the signs and symptoms to look out for, and the tests used to reach a diagnosis.
Join our mailing list and follow the work of the Amyloidosis Alliance, a few emails a year.